Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lansoprazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1214027C details a novel route for PPI intermediates using N-oxide activation, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing solutions.
Patent CN102225909B reveals a one-step synthesis for lansoprazole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102225909B reveals a one-step POCl3 method for 2-chloromethyl-3-methyl-4-trifluoroethoxypyridine, offering significant cost and efficiency advantages for API manufacturers.